Author

J.S. Walz

Observed names: J Walz, J. S. Walz

Institutions: German Cancer Research Center, Universitätsklinikum Tübingen, Deutsches Konsortium für Translationale Krebsforschung, University of Tübingen

Observed institutions: German Cancer Research Center, Universitätsklinikum Tübingen, Deutsches Konsortium für Translationale Krebsforschung, University of Tübingen

OpenAlex ID: A5015470086

Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade

2022 · F Berner, D Bomze, et al. · immuneACCESS · 5

813MO Phase I trial of a personalized multi-peptide vaccine combined with the TLR1/2 ligand XS15 under Bruton-Tyrosine-Kinase inhibitor (BTKi) treatment in chronic lymphocytic leukemia (CLL) patients

2024 · C. Hackenbruch, J.S. Heitmann, et al. · Annals of Oncology · 1

Carfilzomib preserves dendritic cell phenotype and function compared with bortezomib

2026 · L. Wang, M. Dahlfrancis, et al. · Frontiers in Immunology

22P Pre-clinical development of CVGBM: A therapeutic mRNA-based multiepitope vaccine for glioblastoma

2024 · R.I. Mülfarth, J. Lutz, et al. · Annals of Oncology

Works count: 4

Citation count: 6

H-index: 1

I10-index: